Join to access to all OVN content. Join for Free
The most difficult parts of being an MSL and how to overcome them
MSL career KOL relationships MSL challenges time management strategies overcoming MSL burnout

The most difficult parts of being an MSL and how to overcome them


Share This Article


Summary

In this episode, Tom Caravela speaks with Jonathan Horvath about his career journey and insights from the Rutgers fellowship program. Jonathan discusses the complexities and challenges of the MSL role, including organization, territory management, and building relationships with key opinion leaders (KOLs). He addresses internal pressures, performance metrics, and shares strategies for effective time and travel management to combat MSL burnout. The conversation explores navigating different KOL personalities and preparing for meetings. Jonathan also reflects on adapting to COVID-19 and future interactions, offering final advice for aspiring and current MSLs.

My guest today is Jonathan Horvath, former Director of Field Medical Affairs at Dova Pharmaceuticals and we discuss the most difficult parts of being an MSL and how to overcome them.

In this episode we discuss:

  • Jonathan’s background
  • One of the most challenging parts of being an MSL in his perspective
  • KOL access
  • The internal pressures and how to overcome
  • Other challenges and difficulties that MSLs should be aware of to try to stay on top
  • His advice on “MSL frustrations”
  • Advice for MSLs moving into 2021 hopefully coming out of COVID pandemic for them to perform well and get through the challenges
  • One piece of advice for MSLs to help them find success

Click for Source
MSL career, KOL relationships, MSL challenges, time management strategies, overcoming MSL burnout

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Job Search Checklist for Aspiring Medical Science Liaisons
Partner Avatar Tom Caravela

Job Search Checklist for Aspiring Medical Science Liaisons

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Podcast
The Ideal Roadmap for New MSLs
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

The Ideal Roadmap for New MSLs

Article
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
OVN Avatar Laleh Amiri-Kordestani & Richard Pazdur

Oncology approvals in 2020: a year of firsts in the midst of a pandemic

Article
Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities
OVN Avatar Nidal Al-Huniti, Yan Feng, Jingyu (Jerry) Yu, Zheng Lu, Mario Nagase, Diansong Zhou, Jennifer Sheng

Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities

Article
Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2
OVN Avatar Guillaume Beinse, MD, Virgile Tellier, Valentin Charvet, MSc, Eric Deutsch, MD, PhD, Isabelle Borget, PharmD, PhD, Christophe Massard, MD, PhD., Antoine Hollebecque, MD, PhD, and Loic Verlingue, MD

Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2

Explore OVN